WOBURN, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...
Celsius is overvalued based on intrinsic value calculations with a potential 7% drop from the last close. Click here to read ...
Greenpeace filed on Monday an anti-intimidation court case against a U.S. energy company suing the environmental organization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback